Omegaven should be given with caution to patients with an impaired lipid metabolism and uncontrolled diabetes mellitus.
The serum triglyceride level should be monitored daily. Monitoring of blood glucose profiles, acid base metabolism, serum electrolytes, fluid balance, blood count and bleeding time in patients treated with anticoagulants must be carried out regularly. The serum triglyceride concentration should not exceed 3 mmol/L during the infusion of fat emulsions.
Effects on the Ability to Drive or Operate Machinery: Not applicable.